|
Innovative salivary diagnostic tests from OralDNA® Labs are fundamental elements of a patient's wellness plan:
MyPerioPath® - Determines the cause of periodontal infections
In Depth: Identifies the type and concentration of specific perio-pathogenic bacteria that are known to cause periodontal disease. MyPerioPath® helps support the clinician with better risk assessment and personalized treatment options for more predictable patient outcomes.
Patient Profiles:
- Patients presenting with signs and symptoms of a periodontal infection
- Patients with pockets of 4mm or greater with clinical signs of a periodontal infection
- Patients presenting chronic periodontal disease who is not responding positively to
their current treatment
- Patients with Type I or Type II diabetes
- Patients with a history of Cardiovascular disease
- Patients who use tobacco products
- Patients that will undergo surgical procedures or radiation treatment
- Can be used as a "Baseline" for any patient that may be at increased risk for
periodontal infections
- Patients who test positive for genetic susceptibility with the MyPerioID® PST® test
- Women of child bearing age
Click to view sample MyPerioPath® report
MyPerioID® PST® - Determines who is at increased risk for severe periodontal infections
In Depth: Identifies individual genetic susceptibility to periodontal disease and enables the clinician to establish which patients are at increased risk for more severe periodontal infections due to an exaggerated immune response.
Patient Profiles:
- Patients with a family history of periodontal disease
- Patients with compromised immune systems
- Patients that have received therapy but continue with disease activity
- Patients that will receive implants and have lost teeth to periodontal disease
- Adolescent patients
Click to view a sample MyPeriodID® PST ® report
OraRisksm HPV - Determines who is at increased risk for HPV-related oral cancers
In Depth: A non-invasive, easy-to-use screening tool to identify the type(s) of HPV, a mucosal viral infection that could potentially lead to oral cancer. OraRisksm HPV enables the clinician to establish increased risk for oral cancer and determine appropriate referral and monitoring conditions.
Patient Profiles:
- Patients who are sexually active
- Patients with signs and symptoms of oral cancer
- Patients with traditional risk factors for oral cancer
- Patients with suspicious oral lesions
Click to view a sample OraRisksm HPV report
* PST is a registered trademark of
Interleukin Genetics
|